Sunhill Pharma Private Limited
About Sunhill Pharma Private Limited
Data last updated:
Sunhill Pharma Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 September 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85121DL2006PTC153234. Its GSTIN is 05AAKCS5411N2Z3 (Uttarakhand). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5.1 Cr and a paid-up capital of ₹3.16 Cr. It is led by directors Purshotam Lal and Punam Lal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 21 – Community Centre Preet Vihar, Delhi, India – 110092.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.41 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹3.9 Lakh (net margin -114.4%) and EBITDA of -₹3.71 Lakh (EBITDA margin -108.8%). Revenue has grown at a compounded annual rate (CAGR) of 72% over three years and 35% over five years.
As per MCA filings, the company has satisfied charges of ₹13.05 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address21 – Community Centre Preet Vihar, Delhi, India – 110092
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Sunhill Pharma Private Limited FY 2025 filings available
Sunhill Pharma Private Limited reported revenue of ₹3.41 Lakh (up 271% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Sunhill Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 35% over five years, including 271% growth in the latest year. EBITDA fell 503% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Sunhill Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹3.71 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹3.9 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Sunhill Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -108.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -114.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Sunhill Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Sunhill Pharma Private Limited
Sunhill Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nasoterica Labs Private Limited | ₹3.44 Lakh (FY 2025) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Makpar Exports Private Limited | ₹3.43 Lakh (FY 2025) | •••• | •••• | 137.0% | •••• | Mandideep, Madhya Pradesh, India |
| Delta Enterprises Pvt Ltd | ₹3.42 Lakh (FY 2024) | •••• | •••• | -6.0% | •••• | Kolkata, West Bengal, India |
| Lakah Medicos Private Limited | ₹3.42 Lakh (FY 2025) | •••• | •••• | -10.0% | •••• | New Delhi, Delhi, India |
| Yazur Life Sciences Private Limited | ₹3.42 Lakh (FY 2024) | •••• | •••• | 82.0% | •••• | Panchkula, Haryana, India |
| Sunhill Pharma Private Limited this company | ₹3.41 Lakh (FY 2025) | •••• | •••• | 271.0% | •••• | Delhi, India |
| Innova Formulations Private Limited | ₹3.41 Lakh (FY 2025) | •••• | •••• | -8.0% | •••• | New Delhi, Delhi, India |
| SPJ Financial Services Private Limited | ₹3.39 Lakh (FY 2019) | •••• | •••• | 195.0% | •••• | New Delhi, Delhi, India |
| Soniz Meditech Private Limited | ₹3.39 Lakh (FY 2024) | •••• | •••• | 1.0% | •••• | Ahmedabad, Gujarat, India |
| Medexiq Labs Private Limited | ₹3.38 Lakh (FY 2021) | •••• | •••• | -35.0% | •••• | Hyderabad, Telangana, India |
| Vibhav Life Sciences Private Limited | ₹3.38 Lakh (FY 2025) | •••• | •••• | •••• | Ankleshwar, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Sunhill Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Sunhill Pharma Private Limited
Sunhill Pharma Private Limited is audited by DINESH MEHTA & CO. for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| DINESH MEHTA & CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Sunhill Pharma Private Limited
Sunhill Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Purshotam Lal Also directs: Metro Institutes of Medical Sciences Private Limited., Metro Medical Services Limited, Hilsun Pharma Private Limited and 5 more | Director | 07 Sep 2006 | 20 Years 1 Months | Current |
| Punam Lal Also directs: Metro Institutes of Medical Sciences Private Limited., Metro Medical Services Limited, Hilsun Pharma Private Limited and 5 more | Director | 07 Sep 2006 | 20 Years 1 Months | Current |
Ownership and Shareholding of Sunhill Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Sunhill Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Apr 2013 | Punjab National Bank | ₹13.05 Cr | Satisfied |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Sunhill Pharma Private Limited
Employment history and EPFO contributions of people linked to Sunhill Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Sunhill Pharma Private Limited
Sunhill Pharma Private Limited has 2 board changes on record since 2006: 2 appointments. The latest: Punam Lal was appointed as Director on 07 Sep 2006.
Credit Ratings, Litigation & Regulatory Alerts for Sunhill Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Sunhill Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Sunhill Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Sunhill Pharma Private Limited
Sunhill Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAKCS5411N2Z3 | Uttarakhand | Active | 03 Sep 2024 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Sunhill Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sunhill Pharma Private Limited
Sunhill Pharma is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 September 2006 (20+ years old) and is registered under CIN U85121DL2006PTC153234.
Sunhill Pharma reported revenue of ₹3.41 Lakh for FY 2025 (up 271% YoY).
Sunhill Pharma has 2 current directors:
- Purshotam Lal - Director
- Punam Lal - Director
Sunhill Pharma reported a net loss of ₹3.9 Lakh (net margin -114.4%) and EBITDA of -₹3.71 Lakh (EBITDA margin -108.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Sunhill Pharma is 72% over three years and 35% over five years. In the latest year (FY 2025) revenue rose 271%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Sunhill Pharma is 05AAKCS5411N2Z3, registered in Uttarakhand. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Sunhill Pharma is U85121DL2006PTC153234. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sunhill Pharma was incorporated on 07 September 2006, making it 20+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Sunhill Pharma by revenue are Nasoterica Labs Private Limited, Makpar Exports Private Limited, Delta Enterprises Pvt Ltd, Lakah Medicos Private Limited, Yazur Life Sciences Private Limited and 5 more, all in the Pharma industry (Formulations).
Punam Lal was appointed as Director on 07 Sep 2006. Purshotam Lal was appointed as Director on 07 Sep 2006.
The registered office of Sunhill Pharma is at 21 – Community Centre Preet Vihar, Delhi, India – 110092.